{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:05:43Z","timestamp":1788444343450,"version":"build-2803163510"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Oxford Biodynamics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Prostate cancer (PCa) has a high lifetime prevalence (one out of six men), but currently there is no widely accepted screening programme. Widely used prostate specific antigen (PSA) test at cut-off of 3.0 ng\/mL does not have sufficient accuracy for detection of any prostate cancer, resulting in numerous unnecessary prostate biopsies in men with benign disease and false reassurance in some men with PCa. We have recently identified circulating chromosome conformation signatures (CCSs, Episwitch\u00ae PCa test) allowing PCa detection and risk stratification in line with standards of clinical PCa staging. The purpose of this study was to determine whether combining the Episwitch PCa test with the PSA test will increase its diagnostic accuracy. Methods: n = 109 whole blood samples of men enrolled in the PROSTAGRAM screening pilot study and n = 38 samples of patients with established PCa diagnosis and cancer-negative controls from Imperial College NHS Trust were used. Samples were tested for PSA, and the presence of CCSs in the loci encoding for of DAPK1, HSD3B2, SRD5A3, MMP1, and miRNA98 associated with high-risk PCa identified in our previous work. Results: PSA &gt; 3 ng\/mL alone showed a low positive predicted value (PPV) of 0.14 and a high negative predicted value (NPV) of 0.93. EpiSwitch alone showed a PPV of 0.91 and a NPV of 0.32. Combining PSA and Episwitch tests has significantly increased the PPV to 0.81 although reducing the NPV to 0.78. Furthermore, integrating PSA, as a continuous variable (rather than a dichotomised 3 ng\/mL cut-off), with EpiSwitch in a new multivariant stratification model, Prostate Screening EpiSwitch (PSE) test, has yielded a remarkable combined PPV of 0.93 and NPV of 0.95 when tested on the independent combined cohort. Conclusions: Our results demonstrate that combining the standard PSA readout with circulating chromosome conformations (PSE test) allows for significantly enhanced PSA PPV and overall accuracy for PCa detection. The PSE test is accurate, rapid, minimally invasive, and inexpensive, suggesting significant screening diagnostic potential to minimise unnecessary referrals for expensive and invasive MRI and\/or biopsy testing. Further extended prospective blinded validation of the new combined signature in a screening cohort with low cancer prevalence would be the recommended step for PSE adoption in PCa screening.<\/jats:p>","DOI":"10.3390\/cancers15030821","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:19:53Z","timestamp":1675077593000},"page":"821","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-9261","authenticated-orcid":false,"given":"Dmitri","family":"Pchejetski","sequence":"first","affiliation":[{"name":"School of Medicine, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Hunter","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoush","family":"Dezfouli","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Salter","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Powell","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Green","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Naithani","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-3727","authenticated-orcid":false,"given":"Christina","family":"Koutsothanasi","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Alshaker","sequence":"additional","affiliation":[{"name":"School of Medicine, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3223-8155","authenticated-orcid":false,"given":"Jiten","family":"Jaipuria","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"},{"name":"Department of Biotechnology, Amity University, Noida 201313, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-7508","authenticated-orcid":false,"given":"Martin","family":"Connor","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eldred-Evans","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9817-6634","authenticated-orcid":false,"given":"Francesca","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"},{"name":"Nightingale-Saunders Clinical Trials and Epidemiology Unit, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-6723","authenticated-orcid":false,"given":"Hashim","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Akoulitchev","sequence":"additional","affiliation":[{"name":"Oxford BioDynamics Limited, Oxford OX4 2WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Winkler","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,29]]},"reference":[{"key":"ref_1","unstructured":"ACS (2022, October 01). American Cancer Society. Available online: http:\/\/www.cancer.org\/cancer\/prostatecancer\/overviewguide\/prostate-cancer-overview-key-statistics."},{"key":"ref_2","unstructured":"CRUK (2022, October 01). Cancer Research UK. Available online: http:\/\/www.cancerresearchuk.org\/home\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(17)35487-3","article-title":"The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients","volume":"150","author":"Sakr","year":"1993","journal-title":"J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pros.10177","article-title":"Prevalence of PCa and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study","volume":"54","author":"Olmedilla","year":"2003","journal-title":"Prostate"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part B: Prostate and Bladder Tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"b3537","DOI":"10.1136\/bmj.b3537","article-title":"Prostate specific antigen for early detection of PCa: Longitudinal study","volume":"339","author":"Holmstrom","year":"2009","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"119.e19","DOI":"10.1016\/j.urolonc.2015.09.014","article-title":"Stage at presentation and survival outcomes of patients with Gleason 8-10 PCa and low prostate-specific antigen","volume":"34","author":"Falchook","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_9","first-page":"3","article-title":"Finding the Wolf in Sheep\u2019s Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive PCa","volume":"17","author":"Punnen","year":"2015","journal-title":"Rev. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr Follow-up of the European Randomized study of Screening for PCa","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2020.7456","article-title":"Population-Based PCa Screening with Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study","volume":"7","author":"Burak","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.2147\/CMAR.S318404","article-title":"Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?","volume":"13","author":"Yu","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.10092","article-title":"Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma","volume":"35","author":"Schulz","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","article-title":"Hypermethylation of CpG islands in primary and metastatic human PCa","volume":"64","author":"Yegnasubramanian","year":"2004","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22437","DOI":"10.1074\/jbc.M501379200","article-title":"Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in PCa","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1158\/0008-5472.CAN-06-1986","article-title":"TMPRSS2 fusions with oncogenic ETS factors in PCa involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming","volume":"66","author":"Iljin","year":"2006","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.intimp.2013.10.024","article-title":"Formation of distinct chromatin conformation signatures epigenetically regulate macrophage activation","volume":"18","author":"Mukhopadhyay","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1093\/hmg\/dds192","article-title":"Epigenetic markers of PCa in plasma circulating DNA","volume":"21","author":"Cortese","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.1067799","article-title":"Capturing Chromosome Conformation","volume":"295","author":"Dekker","year":"2002","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/pcmr.12258","article-title":"Chromatin barcodes as biomarkers for melanoma","volume":"27","author":"Bastonini","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/CMR.0000000000000182","article-title":"A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma","volume":"25","author":"Jakub","year":"2015","journal-title":"Melanoma Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-021-02710-y","article-title":"Chromatin conformation changes in peripheral blood can detect PCa and stratify disease risk groups","volume":"19","author":"Alshaker","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"990842","DOI":"10.3389\/fonc.2022.990842","article-title":"Monocytes acquire PCa specific chromatin conformations upon indirect co-culture with PCa cells","volume":"12","author":"Alshaker","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ebiom.2018.06.015","article-title":"Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis","volume":"33","author":"Salter","year":"2018","journal-title":"Ebiomedicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12967-018-1387-9","article-title":"Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis","volume":"16","author":"Carini","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_26","unstructured":"Chen, T., and Guestrin, C. (2022, October 15). XGBoost. Available online: https:\/\/arxiv.org\/abs\/1603.02754."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Biecek, P., and Burzykowski, T. (2021). Explanatory Model Analysis, Chapman and Hall\/CRC.","DOI":"10.1201\/9780429027192"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gradin, R., Lindstedt, M., and Johansson, H. (2019). Batch adjustment by reference alignment (BARA): Improved prediction performance in biological test sets with batch effects. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212669"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and Prostate-Cancer Mortality in a Randomized European Study","volume":"360","author":"Hugosson","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e0186873","DOI":"10.1371\/journal.pone.0186873","article-title":"Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1242\/jcs.012328","article-title":"P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma","volume":"120","author":"Christova","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fgene.2016.00194","article-title":"The Genome Conformation as an Integrator of Multi-Omic Data: The Example of Damage Spreading in Cancer","volume":"7","author":"Tordini","year":"2016","journal-title":"Front. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41588-018-0062-7","article-title":"The human noncoding genome defined by genetic diversity","volume":"50","author":"Bartha","year":"2018","journal-title":"Nat. Genet."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/821\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:18:50Z","timestamp":1760120330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,29]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15030821"],"URL":"https:\/\/doi.org\/10.3390\/cancers15030821","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,29]]}}}